Pharmaceutical Gelatin Market Research Report By Application (Capsules, Tablets, Gummies, Supplements), By Formulation Type (Hard Gelatin Capsules, Soft Gelatin Capsules, Gummy Formulations), By Source (Porcine, Bovine, Fish), By End Use (Pharmaceuticals, Nutraceuticals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY SOURCE

6.1. Overview

6.2. Porcine

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

6.3. Bovine Skin

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

6.4. Animal Bones

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

6.5. Others

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

7. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY FUNCTION

7.1. Overview

7.2. Stabilizer

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

7.3. Thickener

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

7.4. Gelling Agent

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

7.5. Others

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY APPLICATION

8.1. Overview

8.2. Hard Capsules

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8.3. Soft Capsules

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8.4. Micro-encapsulation

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8.5. Coating for Tablets

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8.6. Absorbable Hemostat

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

8.7. Others

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

9. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY TYPE

9.1. Overview

9.2. Type A

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

9.3. Type B

Market Estimates & Forecast, by Region, 2018–2030

Market Estimates & Forecast, by Country, 2018–2030

10. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY REGION

10.1. Overview

10.2. North America

10.2.1. US

10.2.2. Canada

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. Italy

10.3.4. Spain

10.3.5. UK

10.3.6. Rest of Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Rest of the World

10.5.1. Middle East

10.5.2. Africa

10.5.3. Latin America

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Pharmaceutical Gelatin Market

11.5. Competitive Benchmarking

11.6. Leading Players in terms of Number of Developments in the Global Pharmaceutical Gelatin Market

11.7. Key Developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial

11.8.1. Sales & Operating Income, 2021

11.8.2. Major Players R&D Expenditure, 2021

12. COMPANY PROFILES

12.1. Darling Ingredients Inc.

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Nitta Gelatin Inc.

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Tessenderlo Group

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Gelita AG

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Weishardt International

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Trobas Gelatine B.V.

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Lonza Group AG

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Lapi Gelatine S.p.A

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Products Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Italgelatine S.p.A

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Products Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Xiamen Gelken Gelatin Co. Ltd.

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Products Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Gelco International

12.11.1. Company Overview

12.11.2. Financial Overview

12.11.3. Products Offered

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

12.12. Aspire Pharmaceuticals

12.12.1. Company Overview

12.12.2. Financial Overview

12.12.3. Products Offered

12.12.4. Key Developments

12.12.5. SWOT Analysis

12.12.6. Key Strategies

12.13. India Gelatine & Chemicals Ltd.

12.13.1. Company Overview

12.13.2. Financial Overview

12.13.3. Products Offered

12.13.4. Key Developments

12.13.5. SWOT Analysis

12.13.6. Key Strategies

12.14. Gelnex Industria E Comercio Ltda

12.14.1. Company Overview

12.14.2. Financial Overview

12.14.3. Products Offered

12.14.4. Key Developments

12.14.5. SWOT Analysis

12.14.6. Key Strategies

12.15. Henan Boom Gelatin Co. Ltd

12.15.1. Company Overview

12.15.2. Financial Overview

12.15.3. Products Offered

12.15.4. Key Developments

12.15.5. SWOT Analysis

12.15.6. Key Strategies

12.16. Baotou Dongbao Bio-Tech Co. Ltd

12.16.1. Company Overview

12.16.2. Financial Overview

12.16.3. Products Offered

12.16.4. Key Developments

12.16.5. SWOT Analysis

12.16.6. Key Strategies

12.17. Norland Products Inc.

12.17.1. Company Overview

12.17.2. Financial Overview

12.17.3. Products Offered

12.17.4. Key Developments

12.17.5. SWOT Analysis

12.17.6. Key Strategies

12.18. Geltech Co. Ltd

12.18.1. Company Overview

12.18.2. Financial Overview

12.18.3. Products Offered

12.18.4. Key Developments

12.18.5. SWOT Analysis

12.18.6. Key Strategies

12.19. Geliko LLC

12.19.1. Company Overview

12.19.2. Financial Overview

12.19.3. Products Offered

12.19.4. Key Developments

12.19.5. SWOT Analysis

12.19.6. Key Strategies

12.20. Kenney & Ross Limited

12.20.1. Company Overview

12.20.2. Financial Overview

12.20.3. Products Offered

12.20.4. Key Developments

12.20.5. SWOT Analysis

12.20.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PHARMACEUTICAL GELATIN MARKET SYNOPSIS, 2018–2030

TABLE 2 GLOBAL PHARMACEUTICAL GELATIN MARKET ESTIMATES & FORECAST, 2018–2030 (USD MILLION)

TABLE 3 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 11 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 12 US: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 13 US: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 14 US: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 15 US: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 16 CANADA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 17 CANADA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 18 CANADA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 19 CANADA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 20 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 21 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 22 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 23 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 24 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 25 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 26 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 27 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 28 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 29 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 30 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 31 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 32 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 33 ITALY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 34 ITALY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 35 ITALY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 36 ITALY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 37 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 38 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 39 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 40 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 41 UK: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 42 UK: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 43 UK: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 44 UK: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 45 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 46 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 47 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 48 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 49 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 50 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 51 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 52 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 53 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 54 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 55 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 56 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 57 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 58 CHINA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 59 CHINA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 60 CHINA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 61 CHINA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 62 INDIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 63 INDIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 64 INDIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 65 INDIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 66 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 67 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 68 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 69 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 70 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 71 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 72 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 73 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY TYPE 2018–2030 (USD MILLION)

TABLE 74 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 75 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 76 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 77 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 78 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 79 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 80 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 81 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 82 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 83 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 84 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 85 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 86 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 87 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 88 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 89 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 90 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 91 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2030 (USD MILLION)

TABLE 92 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2030 (USD MILLION)

TABLE 93 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2030 (USD MILLION)

TABLE 94 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL GELATIN MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL GELATIN MARKET

FIGURE 4 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY SOURCE, 2021

FIGURE 5 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY FUNCTION, 2021

FIGURE 6 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY APPLICATION, 2021

FIGURE 7 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY TYPE, 2021

FIGURE 8 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021

FIGURE 9 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021

FIGURE 10 EUROPE: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021

FIGURE 11 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021

FIGURE 12 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021

FIGURE 13 GLOBAL PHARMACEUTICAL GELATIN MARKET: COMPANY SHARE ANALYSIS (%), 2021

FIGURE 14 DARLING INGREDIENTS INC.: FINANCIAL OVERVIEW

FIGURE 15 DARLING INGREDIENTS INC.: SWOT ANALYSIS

FIGURE 16 NITTA GELATIN INC.: FINANCIAL OVERVIEW

FIGURE 17 NITTA GELATIN INC.: SWOT ANALYSIS

FIGURE 18 TESSENDERLO GROUP: FINANCIAL OVERVIEW

FIGURE 19 TESSENDERLO GROUP: SWOT ANALYSIS

FIGURE 20 GELITA AG: FINANCIAL OVERVIEW

FIGURE 21 GELITA AG: SWOT ANALYSIS

FIGURE 22 WEISHARDT INTERNATIONAL: FINANCIAL OVERVIEW

FIGURE 23 WEISHARDT INTERNATIONAL: SWOT ANALYSIS

FIGURE 24 TROBAS GELATINE B.V.: FINANCIAL OVERVIEW

FIGURE 25 TROBAS GELATINE B.V.: SWOT ANALYSIS

FIGURE 26 LONZA GROUP AG: FINANCIAL OVERVIEW

FIGURE 27 LONZA GROUP AG: SWOT ANALYSIS

FIGURE 28 LAPI GELATINE S.P.A: FINANCIAL OVERVIEW

FIGURE 29 LAPI GELATINE S.P.A: SWOT ANALYSIS

FIGURE 30 ITALGELATINE S.P.A: FINANCIAL OVERVIEW

FIGURE 31 ITALGELATINE S.P.A: SWOT ANALYSIS

FIGURE 32 XIAMEN GELKEN GELATIN CO. LTD.: FINANCIAL OVERVIEW

FIGURE 33 XIAMEN GELKEN GELATIN CO. LTD.: SWOT ANALYSIS

FIGURE 34 GELCO INTERNATIONAL: FINANCIAL OVERVIEW

FIGURE 35 GELCO INTERNATIONAL: SWOT ANALYSIS

FIGURE 36 ASPIRE PHARMACEUTICALS: FINANCIAL OVERVIEW

FIGURE 37 ASPIRE PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 38 INDIA GELATINE & CHEMICALS LTD.: FINANCIAL OVERVIEW

FIGURE 39 INDIA GELATINE & CHEMICALS LTD.: SWOT ANALYSIS

FIGURE 40 GELNEX INDUSTRIA E COMERCIO LTDA: FINANCIAL OVERVIEW

FIGURE 41 GELNEX INDUSTRIA E COMERCIO LTDA: SWOT ANALYSIS

FIGURE 42 HENAN BOOM GELATIN CO. LTD: FINANCIAL OVERVIEW

FIGURE 43 HENAN BOOM GELATIN CO. LTD: SWOT ANALYSIS

FIGURE 44 BAOTOU DONGBAO BIO-TECH CO. LTD: FINANCIAL OVERVIEW

FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: SWOT ANALYSIS

FIGURE 46 NORLAND PRODUCTS INC.: FINANCIAL OVERVIEW

FIGURE 47 NORLAND PRODUCTS INC.: SWOT ANALYSIS

FIGURE 48 GELTECH CO. LTD: FINANCIAL OVERVIEW

FIGURE 49 GELTECH CO. LTD: SWOT ANALYSIS

FIGURE 50 GELIKO LLC: FINANCIAL OVERVIEW

FIGURE 51 GELIKO LLC: SWOT ANALYSIS

FIGURE 52 KENNEY & ROSS LIMITED: FINANCIAL OVERVIEW

FIGURE 53 KENNEY & ROSS LIMITED: SWOT ANALYSIS